SP140L
Nuclear body protein SP140-like protein
Also known as: SP14L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H930
- Gene
- SP140L
- Ensembl
- ENSG00000185404
- Chromosome
- 2
- Canonical length
- 580 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
580 residues, UniProt reviewed canonical sequence.
>Q9H930|SP140L
1 MAGGGSDLST RGLNGGVSQV ANEMNHLPAH SQSLQRLFTE DQDVDEGLVY DTVFKHFKRH
61 KLEISNAIKK TFPFLEGLRD RELITNKMFE DSEDSCRNLV PVQRVVYNVL SELEKTFNLS
121 VLEALFSEVN MQEYPDLIHI YKSFKNAIQD KLSFQESDRK EREERPDIKL SLKQGEVPES
181 PEARKESDQA CGKMDTVDIA NNSTLGKPKR KRRKKKGHGW SRMGTRTQKN NQQNDNSKAD
241 GQLVSSEKKA NMNLKDLSKI RGRKRGKPGT HFTQSDRAPQ KRVRSRASRK HKDETVDFQA
301 PLLPVTCGGV KGILHKEKLE QGTLAKCIQT EDGKWFTPME FEIKGGYARS KNWRLSVRCG
361 GWPLRRLMEE GSLPNPPRIY YRNKKRILKS QNNSSVDPCM RNLDECEVCR DGGELFCCDT
421 CSRVFHEDCH IPPVESEKTP WNCIFCRMKE SPGSQQCCQE SEVLERQMCP EEQLKCEFLL
481 LKVYCCSESS FFAKIPYYYY IREACQGLKE PMWLDKIKKR LNEHGYPQVE GFVQDMRLIF
541 QNHRASYKYK DFGQMGLRLE AEFEKDFKEV FAIQETNGNSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SP140L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- spleen: 25 nTPM
- lymph node: 23 nTPM
- tonsil: 19 nTPM
- appendix: 18 nTPM
- small intestine: 16 nTPM
- liver: 15 nTPM
Single-cell type
- b-cells: 158 nCPM
- t-cells: 81 nCPM
- nk-cells: 77 nCPM
- microglia: 73 nCPM
- urothelial cells: 63 nCPM
- hematopoietic stem cells: 53 nCPM
Immune cell
- naive B-cell: 33 nTPM
- memory B-cell: 30 nTPM
- NK-cell: 23 nTPM
- basophil: 21 nTPM
- naive CD4 T-cell: 20 nTPM
- MAIT T-cell: 19 nTPM
Brain region
- medulla oblongata: 9.5 nTPM
- thalamus: 9 nTPM
- white matter: 8.9 nTPM
- choroid plexus: 8.5 nTPM
- pons: 8.5 nTPM
- cerebral cortex: 7.4 nTPM
ReferencesPubMed · IEDB
Publications for SP140L from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis.
2015 · J Immunol Res · RCR 0.7 · 26 citations - Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region.
2025 · Rheumatology (Oxford) · 3 citations - Anti-Mi2 autoantibodies target the PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily recognize epitopes outside the PHD region of TIF1γ.
2025 · medRxiv · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.09
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SAND domain
- Bromodomain
- Zinc finger, PHD-type
- HSR domain
- SAND-like domain superfamily
- Zinc finger, FYVE/PHD-type
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, PHD-type, conserved site
- Zinc finger, PHD-finger
- Nuclear body protein Sp140, bromodomain
- Bromodomain-like superfamily
- Nuclear body protein Sp110/Sp140/Sp140L-like
- Bromodomain
- PHD-finger
- SAND domain
- HSR domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SP140L as an antibody target. Whether an autoantibody or antibody against SP140L could matter depends on whether native SP140L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SP140L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SP140L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...